ApoA-1和α1-AT预测Ⅲ期非小细胞肺癌同步放化疗敏感性的价值

来源 :疑难病杂志 | 被引量 : 0次 | 上传用户:dldx05444011
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的观测血清载脂蛋白A-1(ApoA-1)和α1-抗胰蛋白酶(α1-AT)水平在预测Ⅲ期非小细胞肺癌(NSCLC)同步放化疗敏感性中的意义。方法 2010年3月—2013年3月收治初次治疗的Ⅲ期NSCLC患者60例,均行同步放化疗方案,分别于放疗前、放疗4周、放疗后检测ApoA-1和α1-AT的水平。结果 NSCLC患者ApoA-1和α1-AT水平女性均明显高于男性(P<0.05);不同TNM分期和不同病理类型NSCLC患者之间血清α1-AT水平也有显著差异(P<0.05),ⅢB期较ⅢA期α1-AT水平有所降低(P<0.05),腺癌及非鳞腺癌患者的血清α1-AT水平低于鳞癌患者(P<0.05)。敏感组和抵抗组的血清ApoA-1、α1-AT水平在放疗前比较差异均有统计学意义(P<0.05);抵抗组和敏感组放疗4周后ApoA-1水平明显降低(P<0.05),放疗结束后敏感组明显升高(P<0.05),而2组α1-AT水平放疗4周和放疗后均低于放疗前(P均<0.05)。ROC曲线提示α1-AT在325.2ng/ml时,对放化疗敏感性的预测敏感性为90.21%、特异性为89.02%,优于ApoA-1(分别为76.31%和87.25%)的预测意义。结论血清ApoA-1和α1-AT水平在预测Ⅲ期非小细胞肺癌患者对于同步放化疗的敏感性方面有着重要的意义。 Objective To investigate the significance of serum apolipoprotein A-1 (ApoA-1) and α1-antitrypsin (α1-AT) in predicting the chemosensitivity of concurrent non-small cell lung cancer (NSCLC) Methods From March 2010 to March 2013, 60 patients with initial stage Ⅲ NSCLC were treated with concurrent chemoradiotherapy. The levels of ApoA-1 and α1-AT were measured before radiotherapy and 4 weeks after radiotherapy. Results The levels of ApoA-1 and α1-AT in NSCLC patients were significantly higher than those in men (P <0.05). The serum levels of α1-AT were also significantly different between NSCLC patients with different TNM stages and different pathological types (P0.05) The level of α1-AT in patients with adenocarcinoma and non-squamous cell carcinoma was lower than that in patients with squamous cell carcinoma (P <0.05). The serum levels of ApoA-1 and α1-AT in the sensitive group and the resistant group were significantly lower than those before the radiotherapy (P <0.05), while the levels of ApoA-1 in the sensitive group and the sensitive group were significantly decreased 4 weeks after radiotherapy ), The sensitive group was significantly increased after radiotherapy (P <0.05), while the α1-AT level in 2 groups was lower than that before radiotherapy (P <0.05) after radiotherapy for 4 weeks and after radiotherapy. The ROC curve suggested that the sensitivity and specificity of α1-AT to chemosensitivity to radiotherapy and chemotherapy were 90.21% and 89.02% at 325.2ng / ml, which were better than those of ApoA-1 (76.31% and 87.25% respectively). Conclusions The serum levels of ApoA-1 and α1-AT are of great importance in predicting the sensitivity of concurrent radiochemotherapy in patients with stage Ⅲ non-small cell lung cancer.
其他文献
通过对不同厚度样品的γ射线测量,得出波谱峰面积与样品厚度的关系,并通过相对测量和效率刻度测量方法,计算不同厚度样品在46.5、351.9、477.6、661.7 keV能量下的探测效率.
离子在样品内的能量岐离将改变中子深度分析(neutron depth profiling,NDP)的多道离子能谱分布.基于SRIM程序,分析了10B(n,α)7Li反应产生的四种离子穿过硅材料后的能最离散
In spite of the rapid developments in communication technologies over the past few decades,which include attractive features offered by the presently used 3G/4G
介绍了SAUNA惰性气体氙移动取样系统的组成和基本功能,684 h取样性能研究结果表明,该系统拆卸、组装方便,性能稳定,氙取样量的平均值为2.2 mL/d,具备连续多天高效取样的能力.
介绍了一种脉宽在0.45-8.5μs、幅度在100-300 V内可调,脉冲上升时间<30 ns的电源研制方案,阐述了电源的工作原理及调试过程.实验结果表明,设计的快脉冲电源稳定性高、电路简
介绍了3He半导体夹心谱仪的探头组件和电子学系统,开展了热中子调试,获得快中子临界装置上0.1-1.3 MeV的能谱数据.测量结果与6Li夹心谱仪在0.3-1.3 MeV范围非常符合,证明该谱
碳纳米管(NTs)易吸附环境中各种有毒金属离子,形成复合物,其生物效应和毒性有别于CNTs和金属离子单独作用及两重材料简单生物效应的叠加效果.阐述了金属离子在CNTs上吸附概况
2011年2月25日,第十一届中国房地产发展年会在北京国贸大酒店群贤宴会厅顺利举行。本次发展年会共邀请了逾两千名地产精英和专家学者前来参加。其中包括万科、远洋、中海、龙
目的分析研究伊立替康单药二线治疗进展期结直肠癌的临床价值。方法盲选本院收治的66例进展期结直肠癌患者,给予患者采用伊立替康单药二线治疗,分析评价其临床价值。结果 66
目的 研究异丙肾上腺素 (isoprenaline,Iso)诱导大鼠急性心肌缺血与心肌细胞凋亡相关基因表达的关系。方法 sc大剂量Iso建立大鼠急性心肌缺血模型。RT PCR法检测凋亡相关基